GlakoLens
PrivateLast Round
Accelerator
Mar 21, 2025
Total Funding Raised
$1.38M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlakoLens operates in Healthcare & Life Sciences and is based in Turkey. Its latest recorded funding round was an Accelerator round in March 2025.
GlakoLens is a medtech company that develops a contact lens-based biosensor technology for intraocular pressure and glaucoma management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlakoLens Comparables
Compare GlakoLens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BVS Sight Inc. | 90% | |
| Smartlens | 89% | |
| SEED Co., Ltd. | 84% |
For institutional investors. Book with your work email.
GlakoLens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 21, 2025 | ||||
| Grant | Oct 15, 2019 | ||||
| Grant | Sep 21, 2017 | ||||
| Seed | May 25, 2017 |
For institutional investors. Book with your work email.
GlakoLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| ETH Zurich | Grant |
| European Commission | Grant |
| Eurostars SME programme | Grant |
| Accelerace | Accelerator |
| CDP Venture Capital SGR | Accelerator |
| VITA Accelerator | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 1200% MoM, from 6 to 78.
- Jun 20, 2026
Monthly visitors increased 484% MoM.
For institutional investors. Book with your work email.
GlakoLens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlakoLens's valuation, stock price, and market status.
Is GlakoLens a public or private company?
GlakoLens is a private company.
What is the current stock price of GlakoLens?
GlakoLens is a private company, so its shares have no public market price. Caplight tracks GlakoLens's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlakoLens worth (valuation)?
Valuation information for GlakoLens is not publicly available.
Can I buy GlakoLens stock?
GlakoLens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlakoLens's last funding round?
GlakoLens's most recent funding round was Accelerator on March 21, 2025.
Who are the main investors in GlakoLens?
Key investors in GlakoLens include VITA Accelerator, ACT Venture Partners.
Will GlakoLens IPO soon?
No public IPO plans have been announced for GlakoLens.
How can I track GlakoLens secondary market activity?
Caplight tracks bids, offers, and trades in GlakoLens's shares on secondary markets.